(S)-2-((5-nitropyridin-2-yl)amino)propan-1-ol, 95+%, 100mg

(1-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)boronic acid, 95+%, 1g

Juntas con orificio, GL 32, 18 mm, 2 Pieza(s)

PFI-1, 95%, 1g

Enoxacin Sesquihydrate>98.0%(HPLC)(T)25g

Methyl 2-amino-3-phenylpropanoate hydrochloride, 98.0%, 25g

2,2'-Bipyridine-5-carboxylic acid, 97.0%, 1g

4-Methoxyphenyl isothiocyanate, 98.0%, 5g

3,3',5,5'-Tetra-tert-butyl-[1,1'-biphenyl]-2,2'-diol, 98.0%, 5g

1H-Isoindole-1,3(2H)-dione, 5-amino-2-[2,6-bis(1-methylethyl)phenyl]-, 97%, 5mg

3-(3-bromophenyl)-4'-methoxypropiophenone, 97.0%, 1g

tert-Butyl 4-bromo-2,6-difluorobenzoate, 97.0%, 25g

2',3'-Dichloro-2,2,2-trifluoroacetophenone, 97.0%, 250mg